论文部分内容阅读
本文观察了铜仿膜透析器首次使用综合征的临床表现及其对透析患者ＩＬ－１（白细胞介素１）、ＴＮＰα（肿瘤坏死因子α）和Ｃ３（补体３）的影响。结果发现：透析后１ｈ患者ＩＬ－１、ＴＮＦα和Ｃ３水平明显升高（Ｐ＜０．０１），与透析后１ｈ首次使用综合征症状发生率较高相一致。膜的生物相容性是首次使用综合征的重要原因，新透析器高通透性是首次使用中症状性低血压的原因。
In this paper, we observed the clinical manifestations of first use syndrome of broncho-membrane dialyzer and its effect on the levels of IL-1 (interleukin 1), TNPα (tumor necrosis factor α) and C3 (complement 3) in dialysis patients. The results showed that the levels of IL-1, TNFα and C3 were significantly increased at 1 hour after dialysis (P <0.01), which was consistent with the higher incidence of first-time symptoms at 1 hour after dialysis. The biocompatibility of the membrane is an important reason for the first use of the syndrome. The high permeability of the new dialyzer is the cause of symptomatic hypotension during initial use.